The Expression of NRIP1 and LCOR in Endometrioid Endometrial Cancer

xlomafota13 shared this article with you from Inoreader The Expression of NRIP1 and LCOR in Endometrioid Endometrial Cancer Via In vivo (Athens, Greece) In Vivo. 2021 Sep-Oct;35(5):2631-2640. doi: 10.21873/invivo.12545. ABSTRACT BACKGROUND: The aim of the study was to analyze the expression of nuclear receptor interacting protein 1 (NRIP1) and its partner ligand-dependent nuclear receptor co-repressor (LCOR) in endometrioid endometrial cancer and to investigate their association with estrogen receptor (ER), progesterone receptor (PR), Ki-67, clinicopathological parameters and patient survival. MATERIALS AND METHODS: Immunohistochemical evaluation was carried out to investigate the subcellular expression of NRIP1 and LCOR in endometrioid endometrial cancer samples. Statistical analysis was used to identify the correlations of NRIP1 and LCOR expression with clinicopathological variables and to estimate the survival rates. RESULTS: Endometrial cancer tissues exhibited higher expression of NRIP1 and LCOR in comparison with the normal tissues. Cytoplasmic LCOR expression was pos itively associated with ER and PR expression, while cytoplasmic NRIP1 expression was positively associated with ER expression. Moreover, cytoplasmic expression of NRIP1 was positively associated with Ki-67. CONCLUSION: Our study demonstrated that high cytoplasmic expression of LCOR may predict a longer overall survival of patients with endometrioid endometrial cancer. Patients with tumors expressing low levels of LCOR showed a worse survival compared to those expressing high levels. PMID:34410950 | DOI:10.21873/invivo.12545 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.